Norges Bank Infla Rx N.V. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 23, 2018	SELL	$27.33 - $41.46 $2.46 Million - $3.73 Million	-90,000 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$20.21 - $32.0 $1.82 Million - $2.88 Million	90,000 New	90,000 $2.6 Million
Q1 2018 May 09, 2018	SELL	$20.21 - $32.0 $1.82 Million - $2.88 Million	-90,000 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$14.55 - $23.99 $1.31 Million - $2.16 Million	90,000	90,000 $1.89 Million

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.